Virios Therapeutics, Inc. /
Pharmagesic (Holdings) Inc.
Virios Therapeutics combines with Pharmagesic (Holdings) Inc.
What happened
Virios Therapeutics, Inc. acquired all of the issued and outstanding common shares of Pharmagesic (Holdings) Inc. on Oct. 7, 2024.
Sealbond Limited was Pharmagesic’s sole shareholder. In exchange for the shares, Virios Therapeutics will issue Sealbond common stock and Series A Non-Voting Convertible Preferred Stock.
The source
Everything on this page comes from the source below.
Virios Therapeutics combines with Pharmagesic (Holdings) Inc.
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly